Insights into Allosteric Mechanisms of the Lung-Enriched p53 Mutants V157F and R158L

Lung cancer is a leading fatal malignancy in humans. p53 mutants exhibit not only loss of tumor suppressor capability but also oncogenic gain-of-function, contributing to lung cancer initiation, progression and therapeutic resistance. Research shows that p53 mutants V157F and R158L occur with high f...

Descripción completa

Detalles Bibliográficos
Autores principales: Lei, Jiangtao, Li, Xuanyao, Cai, Mengqiang, Guo, Tianjing, Lin, Dongdong, Deng, Xiaohua, Li, Yin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456101/
https://www.ncbi.nlm.nih.gov/pubmed/36077492
http://dx.doi.org/10.3390/ijms231710100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456101/
https://www.ncbi.nlm.nih.gov/pubmed/36077492
http://dx.doi.org/10.3390/ijms231710100

Ejemplares similares